Naturally occurring regulatory T cells: Recent insights in health and disease

Giorgio Raimondi, Michael S. Turner, Angus W. Thomson, Penelope A. Morel

Research output: Contribution to journalArticle

Abstract

Development of naturally occurring CD4+CD25+ T regulatory cells (Treg) in the thymus requires the transcription factor Foxp3. Major histocompatibility complex (MHC) class II, self-ligands expressed by epithelial cells, and thymic stromal lymphopoietin also appear to play important roles. In addition, several molecular regulators of T-cell receptor (TCR) signaling (both positive and negative) have been implicated in the control of Treg development. Foxp3 is a transcriptional repressor of IL-2 and other cytokines and appears to maintain the anergic and suppressor function of these cells. Multiple cell types (T cells, B cells, dendritic cells [DC], and natural killer [NK] cells) are targeted by Treg using diverse suppressor mechanisms, whereas factors that regulate Treg proliferation and function, including Toll-like receptor (TLR) ligands, have also been identified. Because Treg play an important role in the control of autoimmunity, therapeutic strategies are being pursued to enhance their numbers and function in specific autoimmune diseases. In transplantation, where Treg also offer potential for therapy of rejection and graft-versus-host disease (GVHD), indirect allorecognition may be the dominant pathway for immune regulation by these cells. In tumor immunology, Treg have emerged as major suppressors of T-cell-mediated antitumor responses and represent a significant obstacle to effective anticancer vaccines. Strategies aimed at depletion/functional inhibition of these cells by molecular targeting must maintain a critical balance between tumor immunity and self-tolerance.

Original languageEnglish (US)
Pages (from-to)61-95
Number of pages35
JournalCritical Reviews in Immunology
Volume27
Issue number1
StatePublished - 2007
Externally publishedYes

Fingerprint

Regulatory T-Lymphocytes
Health
Ligands
T-Lymphocytes
Self Tolerance
Natural Killer T-Cells
Toll-Like Receptors
Graft vs Host Disease
T-Cell Antigen Receptor
Allergy and Immunology
Major Histocompatibility Complex
Autoimmunity
Dendritic Cells
Thymus Gland
Autoimmune Diseases
Interleukin-2
Immunity
Neoplasms
B-Lymphocytes
Transcription Factors

Keywords

  • Autoimmune disease
  • Cancer
  • CTLA-4
  • Cytokines
  • Foxp3
  • Regulatory T cells
  • TCR
  • Thymus
  • Transplantation

ASJC Scopus subject areas

  • Immunology

Cite this

Naturally occurring regulatory T cells : Recent insights in health and disease. / Raimondi, Giorgio; Turner, Michael S.; Thomson, Angus W.; Morel, Penelope A.

In: Critical Reviews in Immunology, Vol. 27, No. 1, 2007, p. 61-95.

Research output: Contribution to journalArticle

Raimondi, Giorgio ; Turner, Michael S. ; Thomson, Angus W. ; Morel, Penelope A. / Naturally occurring regulatory T cells : Recent insights in health and disease. In: Critical Reviews in Immunology. 2007 ; Vol. 27, No. 1. pp. 61-95.
@article{335778e21d454ea594bfa22468d109bb,
title = "Naturally occurring regulatory T cells: Recent insights in health and disease",
abstract = "Development of naturally occurring CD4+CD25+ T regulatory cells (Treg) in the thymus requires the transcription factor Foxp3. Major histocompatibility complex (MHC) class II, self-ligands expressed by epithelial cells, and thymic stromal lymphopoietin also appear to play important roles. In addition, several molecular regulators of T-cell receptor (TCR) signaling (both positive and negative) have been implicated in the control of Treg development. Foxp3 is a transcriptional repressor of IL-2 and other cytokines and appears to maintain the anergic and suppressor function of these cells. Multiple cell types (T cells, B cells, dendritic cells [DC], and natural killer [NK] cells) are targeted by Treg using diverse suppressor mechanisms, whereas factors that regulate Treg proliferation and function, including Toll-like receptor (TLR) ligands, have also been identified. Because Treg play an important role in the control of autoimmunity, therapeutic strategies are being pursued to enhance their numbers and function in specific autoimmune diseases. In transplantation, where Treg also offer potential for therapy of rejection and graft-versus-host disease (GVHD), indirect allorecognition may be the dominant pathway for immune regulation by these cells. In tumor immunology, Treg have emerged as major suppressors of T-cell-mediated antitumor responses and represent a significant obstacle to effective anticancer vaccines. Strategies aimed at depletion/functional inhibition of these cells by molecular targeting must maintain a critical balance between tumor immunity and self-tolerance.",
keywords = "Autoimmune disease, Cancer, CTLA-4, Cytokines, Foxp3, Regulatory T cells, TCR, Thymus, Transplantation",
author = "Giorgio Raimondi and Turner, {Michael S.} and Thomson, {Angus W.} and Morel, {Penelope A.}",
year = "2007",
language = "English (US)",
volume = "27",
pages = "61--95",
journal = "Critical Reviews in Immunology",
issn = "1040-8401",
publisher = "Begell House Inc.",
number = "1",

}

TY - JOUR

T1 - Naturally occurring regulatory T cells

T2 - Recent insights in health and disease

AU - Raimondi, Giorgio

AU - Turner, Michael S.

AU - Thomson, Angus W.

AU - Morel, Penelope A.

PY - 2007

Y1 - 2007

N2 - Development of naturally occurring CD4+CD25+ T regulatory cells (Treg) in the thymus requires the transcription factor Foxp3. Major histocompatibility complex (MHC) class II, self-ligands expressed by epithelial cells, and thymic stromal lymphopoietin also appear to play important roles. In addition, several molecular regulators of T-cell receptor (TCR) signaling (both positive and negative) have been implicated in the control of Treg development. Foxp3 is a transcriptional repressor of IL-2 and other cytokines and appears to maintain the anergic and suppressor function of these cells. Multiple cell types (T cells, B cells, dendritic cells [DC], and natural killer [NK] cells) are targeted by Treg using diverse suppressor mechanisms, whereas factors that regulate Treg proliferation and function, including Toll-like receptor (TLR) ligands, have also been identified. Because Treg play an important role in the control of autoimmunity, therapeutic strategies are being pursued to enhance their numbers and function in specific autoimmune diseases. In transplantation, where Treg also offer potential for therapy of rejection and graft-versus-host disease (GVHD), indirect allorecognition may be the dominant pathway for immune regulation by these cells. In tumor immunology, Treg have emerged as major suppressors of T-cell-mediated antitumor responses and represent a significant obstacle to effective anticancer vaccines. Strategies aimed at depletion/functional inhibition of these cells by molecular targeting must maintain a critical balance between tumor immunity and self-tolerance.

AB - Development of naturally occurring CD4+CD25+ T regulatory cells (Treg) in the thymus requires the transcription factor Foxp3. Major histocompatibility complex (MHC) class II, self-ligands expressed by epithelial cells, and thymic stromal lymphopoietin also appear to play important roles. In addition, several molecular regulators of T-cell receptor (TCR) signaling (both positive and negative) have been implicated in the control of Treg development. Foxp3 is a transcriptional repressor of IL-2 and other cytokines and appears to maintain the anergic and suppressor function of these cells. Multiple cell types (T cells, B cells, dendritic cells [DC], and natural killer [NK] cells) are targeted by Treg using diverse suppressor mechanisms, whereas factors that regulate Treg proliferation and function, including Toll-like receptor (TLR) ligands, have also been identified. Because Treg play an important role in the control of autoimmunity, therapeutic strategies are being pursued to enhance their numbers and function in specific autoimmune diseases. In transplantation, where Treg also offer potential for therapy of rejection and graft-versus-host disease (GVHD), indirect allorecognition may be the dominant pathway for immune regulation by these cells. In tumor immunology, Treg have emerged as major suppressors of T-cell-mediated antitumor responses and represent a significant obstacle to effective anticancer vaccines. Strategies aimed at depletion/functional inhibition of these cells by molecular targeting must maintain a critical balance between tumor immunity and self-tolerance.

KW - Autoimmune disease

KW - Cancer

KW - CTLA-4

KW - Cytokines

KW - Foxp3

KW - Regulatory T cells

KW - TCR

KW - Thymus

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=34247493188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247493188&partnerID=8YFLogxK

M3 - Article

C2 - 17430097

AN - SCOPUS:34247493188

VL - 27

SP - 61

EP - 95

JO - Critical Reviews in Immunology

JF - Critical Reviews in Immunology

SN - 1040-8401

IS - 1

ER -